The drugmaker plans to launch Semaglutide in 87 countries next year, including those where patents are expiring and emerging ...

Q2 2025 has demonstrated the pharmaceutical industry’s continued momentum in developing transformative therapies across ...

Demand for glucagon-like peptide-1 weight-loss drugs — such as Ozempic, Zepbound and Wegovy — coupled with limited insurance coverage has fueled a risky but growing “gray” market for purchasing active ...

The study found that weight regain varied with follow-up, with participants experiencing weight regain at eight, 12, and 20 ...

A new study in mice shows that tirzepatide—the active ingredient in the popular drugs Mounjaro and Zepbound—not only helps shed pounds but may also slow or reduce the growth of breast cancer tumors ...

New research reveals weight-loss drugs help during treatment but weight returns rapidly after stopping. Experts urge ...

With the sales of weight-loss drugs booming, India is now the epicentre of the global obesity treatment market, reports The ...

THEY have taken the nation’s waistlines by storm, helping thousands shed pounds and trim inches. So-called fat jabs have been dubbed a “miracle” – helping turn the tide on ...

Curious about the viral “Japanese Mounjaro” drink? Learn what it is, what it’s made of, and whether it can actually support ...

The hormonal changes of menopause can make the weight gain more resistant to traditional diet and lifestyle changes. But GLP-1s can be an effective reinforcement of diet and exercise.

A retrospective cohort study found that semaglutide and tirzepatide are linked with significantly lower risks of dementia and ...

Copycats and false advertisements are also to blame for the increased threats. Stemming from social media testimonials all ...